|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-An update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uddin A and Chakraborty S: Role of miRNAs
in lung cancer. J Cell Physiol. 2018. View Article : Google Scholar
|
|
8
|
Ma YS, Yu F, Zhong XM, Lu GX, Cong XL, Xue
SB, Xie WT, Hou LK, Pang LJ, Wu W, et al: miR-30 family reduction
maintains self-renewal and promotes tumorigenesis in
NSCLC-initiating cells by targeting oncogene TM4SF1. Mol Ther.
26:2751–2765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song Q, Ji Q, Xiao J, Wang L, Chen Y, Xu Y
and Jiao S: miR-409 inhibits human non-small-cell lung cancer
progression by directly targeting SPIN1. Mol Ther Nucleic Acids.
13:154–163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hovey AM, Devor EJ, Breheny PJ, Mott SL,
Dai D, Thiel KW and Leslie KK: miR-888: A novel cancer-testis
antigen that targets the progesterone receptor in endometrial
cancer. transl Oncol. 8:85–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao SJ, Chen L, Lu W, Zhang L, Wang L and
Zhu HH: miR-888 functions as an oncogene and predicts poor
prognosis in colorectal cancer. Oncol Lett. 15:9101–9109.
2018.PubMed/NCBI
|
|
12
|
Bobowicz M, Skrzypski M, Czapiewski P,
Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A,
Zegarski W, Pawłowski R, Polańska J, et al: Prognostic value of
5-microRNA based signature in T2-T3N0 colon cancer. Clin Exp
Metastasis. 33:765–773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewis H, Lance R, Troyer D, Beydoun H,
Hadley M, Orians J, Benzine T, Madric K, Semmes OJ, Drake R, et al:
miR-888 is an expressed prostatic secretions-derived microRNA that
promotes prostate cell growth and migration. Cell Cycle.
13:227–239. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang S and Chen L: MiR-888 regulates side
population properties and cancer metastasis in breast cancer cells.
Biochem Biophys Res Commun. 450:1234–1240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang S, Cai M, Zheng Y, Zhou L, Wang Q
and Chen L: miR-888 in MCF-7 side population sphere cells directly
targets E-cadherin. J Genet Genomics. 41:35–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hasegawa T, Glavich GJ, Pahuski M, Short
A, Semmes OJ, Yang L, Galkin V, Drake R and Esquela-Kerscher A:
Characterization and evidence of the miR-888 cluster as a novel
cancer network in prostate. Mol Cancer Res. 16:669–681. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Liu Q, Lin D and Lai M: CD44v6
down-regulation is an independent prognostic factor for poor
outcome of colorectal carcinoma. Int J Clin Exp Patho.
8:14283–14293. 2015.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bonte D, Lindvall C, Liu H, Dykema K,
Furge K and Weinreich M: Cdc7-Dbf4 kinase overexpression in
multiple cancers and tumor cell lines is correlated with p53
inactivation. Neoplasia. 10:920–931. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Xie W, Wang N, Li C and Wang M:
CDC7-dependent transcriptional regulation of RAD54L is essential
for tumorigenicity and radio-resistance of glioblastoma. Transl
Oncol. 11:300–306. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sasi NK, Bhutkar A, Lanning NJ, MacKeigan
JP and Weinreich M: DDK promotes tumor chemoresistance and survival
via multiple pathways. Neoplasia. 19:439–450. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen C, Xue S, Zhang J, Chen W, Gong D,
Zheng J, Ma J, Xue W, Chen Y, Zhai W, et al:
DNA-methylation-mediated repression of miR-766-3p promotes cell
proliferation via targeting SF2 expression in renal cell carcinoma.
Int J Cancer. 141:1867–1878. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang C, Ma X, Guan G, Liu H, Yang Y, Niu
Q, Wu Z, Jiang Y, Bian C, Zang Y and Zhuang L: MicroRNA-766
promotes cancer progression by targeting NR3C2 in hepatocellular
carcinoma. FASEB J. 33:1456–1467. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masai H and Arai K: Cdc7 kinase complex: A
key regulator in the initiation of DNA replication. J Cell Physiol.
190:287–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Labib K: How do Cdc7 and cyclin-dependent
kinases trigger the initiation of chromosome replication in
eukaryotic cells? Genes Dev. 24:1208–1219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Datta A, Ghatak D, Das S, Banerjee T, Paul
A, Butti R, Gorain M, Ghuwalewala S, Roychowdhury A, Alam SK, et
al: p53 gain-of-function mutations increase Cdc7-dependent
replication initiation. EMBO Rep. 18:2030–2050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Erbayraktar Z, Alural B, Erbayraktar RS
and Erkan EP: Cell division cycle 7-kinase inhibitor PHA-767491
hydrochloride suppresses glioblastoma growth and invasiveness.
Cancer Cell Int. 16:882016. View Article : Google Scholar : PubMed/NCBI
|
